Iwamoto Hiroaki 岩本大旭

Researcher Number	90847245
Other IDs	https://orcid.org/0000-0003-3599-2217
Affiliation (Current)	2025: 金沢大学, 附属病院, 助教
Affiliation (based on the past Project Information) *help	2022 – 2024: 金沢大学, 附属病院, 助教 2021: 金沢大学, 医学系, 助教
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related Except Principal Investigator Basic Section 56030:Urology-related
Keywords	Principal Investigator 前立腺癌 / カフェストール / カーウェオール / カバジタキセル / 神経内分泌 / ドセタキセル / 神経内分泌前立腺癌 / ジテルペン / コーヒー / 免疫機構 … More / ケモカイン / カバジタキセル耐性 / 去勢抵抗性前立腺癌 / 耐性化 / CCR2 / Coffee / CCL2 / Resistant / CRPC / Cabazitaxel … More Except Principal Investigator 免疫薬物複合体 / 細胞接着 / 免疫チェックポイント / TIGIT / PVR / ケモカイン / 去勢抵抗性前立腺癌 / FGF / KRAS / ダブルネガティブ去勢抵抗性 / 前立腺癌 Less

尿路上皮癌の免疫チェックポイント分子をターゲットとした新規治療戦略
- Principal Investigator
  
  八重樫洋
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kanazawa University
治療抵抗性前立腺癌に対するコーヒージテルペン作用機序の解明と新規治療法の開発Principal Investigator
- Principal Investigator
  
  岩本大旭
- Project Period (FY)
  2023 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kanazawa University
KRAS活性を介したダブルネガティブ去勢抵抗性前立腺癌進展機構の解明
- Principal Investigator
  
  泉浩二
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kanazawa University
Elucidation of the mechanism of action of chemokines and immune mechanisms in the acquisition of cabazitaxel resistancePrincipal Investigator
- Principal Investigator
  
  Iwamoto Hiroaki
- Project Period (FY)
  2021 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kanazawa University

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?2023
- Author(s)
  NAKAGAWA RYUNOSUKE、IWAMOTO HIROAKI、NAITO RENATO、KADOMOTO SUGURU、YAEGASHI HIROSHI、KAWAGUCHI SHOHEI、NOHARA TAKAHIRO、SHIGEHARA KAZUYOSHI、IZUMI KOUJI、KADONO YOSHIFUMI、MIZOKAMI ATSUSHI
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 3 Pages: 1351-1359
- DOI
  10.21873/anticanres.16283
- Data Source
  KAKENHI-PROJECT-21K16728
[Journal Article] Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer2022
- Author(s)
  Iwamoto Hiroaki、Izumi Kouji、Nakagawa Ryunosuke、Toriumi Ren、Aoyama Shuhei、Kamijima Taiki、Shimada Takafumi、Kano Hiroshi、Makino Tomoyuki、Naito Renato、Kadomoto Suguru、Yaegashi Hiroshi、Kawaguchi Shohei、Nohara Takahiro、Shigehara Kazuyoshi、Kadono Yoshifumi、Mizokami Atsushi
- Journal Title
  
  Biomedicines
  
  Volume: 10 Issue: 10 Pages: 2369-2369
- DOI
  10.3390/biomedicines10102369
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16728
[Journal Article] Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.2021
- Author(s)
  Iwamoto H, Kano H, Shimada T, Naito R, Makino T, Kadomoto S, Yaegashi H, Shigehara K, Izumi K, Kadono Y, Mizokami A.
- Journal Title
  
  In Vivo
  
  Volume: 35 Issue: 3 Pages: 1703-1709
- DOI
  10.21873/invivo.12430
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09685, KAKENHI-PROJECT-21K16728
[Presentation] KRAS活性を介した去勢抵抗性前立腺癌進展機構2022
- Author(s)
  神島泰樹, 泉浩二, 鳥海蓮, 中川竜之介, 青山周平, 加納洋, 島田貴史, 門本卓, 内藤伶奈人, 岩本大旭, 角野佳史, 溝上敦
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-22K09495

1. 泉浩二 (80646787)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. 溝上敦 (50248580)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
3. 八重樫洋 (00835275)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 高澤啓 (00593021)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Iwamoto Hiroaki 岩本 大旭

Research Projects

Research Products

Co-Researchers

尿路上皮癌の免疫チェックポイント分子をターゲットとした新規治療戦略

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

治療抵抗性前立腺癌に対するコーヒージテルペン作用機序の解明と新規治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

KRAS活性を介したダブルネガティブ去勢抵抗性前立腺癌進展機構の解明

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of the mechanism of action of chemokines and immune mechanisms in the acquisition of cabazitaxel resistancePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Is it Necessary to Treat all Metastatic Prostate Cancer With Upfront Androgen Receptor Axis-targeted Agents?2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] KRAS活性を介した去勢抵抗性前立腺癌進展機構2022

Author(s)

Organizer

Data Source

Iwamoto Hiroaki 岩本大旭